Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface

被引:206
作者
Lewis, Steven M. [1 ]
Wu, Xiufeng [2 ]
Pustilnik, Anna [2 ]
Sereno, Arlene [2 ]
Huang, Flora [2 ]
Rick, Heather L.
Guntas, Gurkan [1 ]
Leaver-Fay, Andrew [1 ]
Smith, Eric M. [2 ]
Ho, Carolyn [2 ]
Hansen-Estruch, Christophe [2 ]
Chamberlain, Aaron K. [2 ]
Truhlar, Stephanie M. [2 ]
Conner, Elaine M.
Atwell, Shane [2 ]
Kuhlman, Brian [1 ,3 ]
Demarest, Stephen J. [2 ]
机构
[1] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA
[2] Eli Lilly Biotechnol Ctr, San Diego, CA USA
[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
CANCER-THERAPY; TUMOR-GROWTH; SPECIFICITY; BINDING; STABILITY; DOMAIN; HETERODIMERIZATION; TRASTUZUMAB; SURVIVAL; INHIBIT;
D O I
10.1038/nbt.2797
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Robust generation of IgG bispecific antibodies has been a long-standing challenge. Existing methods require extensive engineering of each individual antibody, discovery of common light chains, or complex and laborious biochemical processing. Here we combine computational and rational design approaches with experimental structural validation to generate antibody heavy and light chains with orthogonal Fab interfaces. Parental monoclonal antibodies incorporating these interfaces, when simultaneously co-expressed, assemble into bispecific IgG with improved heavy chain-light chain pairing. Bispecific IgGs generated with this approach exhibit pharmacokinetic and other desirable properties of native IgG, but bind target antigens monovalently. As such, these bispecific reagents may be useful in many biotechnological applications.
引用
收藏
页码:191 / +
页数:12
相关论文
共 44 条
[1]   Computational redesign of endonuclease DNA binding and cleavage specificity [J].
Ashworth, Justin ;
Havranek, James J. ;
Duarte, Carlos M. ;
Sussman, Django ;
Monnat, Raymond J., Jr. ;
Stoddard, Barry L. ;
Baker, David .
NATURE, 2006, 441 (7093) :656-659
[2]   Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site [J].
Bostrom, Jenny ;
Yu, Shang-Fan ;
Kan, David ;
Appleton, Brent A. ;
Lee, Chingwei V. ;
Billeci, Karen ;
Man, Wenyan ;
Peale, Franklin ;
Ross, Sarajane ;
Wiesmann, Christian ;
Fuh, Germaine .
SCIENCE, 2009, 323 (5921) :1610-1614
[3]   PCR-based gene synthesis and protein NMR spectroscopy [J].
Casimiro, DR ;
Wright, PE ;
Dyson, HJ .
STRUCTURE, 1997, 5 (11) :1407-1412
[4]   Bispecific antibodies for cancer therapy The light at the end of the tunnel? [J].
Chames, Patrick ;
Baty, Daniel .
MABS, 2009, 1 (06) :539-547
[5]   Predicting protein structures with a multiplayer online game [J].
Cooper, Seth ;
Khatib, Firas ;
Treuille, Adrien ;
Barbero, Janos ;
Lee, Jeehyung ;
Beenen, Michael ;
Leaver-Fay, Andrew ;
Baker, David ;
Popovic, Zoran ;
Players, Foldit .
NATURE, 2010, 466 (7307) :756-760
[6]   Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics [J].
De Groot, Anne S. ;
Martin, William .
CLINICAL IMMUNOLOGY, 2009, 131 (02) :189-201
[7]  
Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675
[8]   Characterization of Inhibitory Anti-insulin-like Growth Factor Receptor Antibodies with Different Epitope Specificity and Ligand-blocking Properties IMPLICATIONS FOR MECHANISM OF ACTION IN VIVO [J].
Doern, Adam ;
Cao, Xianjun ;
Sereno, Arlene ;
Reyes, Christopher L. ;
Altshuler, Angelina ;
Huang, Flora ;
Hession, Cathy ;
Flavier, Albert ;
Favis, Michael ;
Tran, Hon ;
Ailor, Eric ;
Levesque, Melissa ;
Murphy, Tracey ;
Berquist, Lisa ;
Tamraz, Susan ;
Snipas, Tracey ;
Garber, Ellen ;
Shestowsky, William S. ;
Rennard, Rachel ;
Graff, Christilyn P. ;
Wu, Xiufeng ;
Snyder, William ;
Cole, Lindsay ;
Gregson, David ;
Shields, Michael ;
Ho, Steffan N. ;
Reff, Mitchell E. ;
Glaser, Scott M. ;
Dong, Jianying ;
Demarest, Stephen J. ;
Hariharan, Kandasamy .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (15) :10254-10267
[9]   Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity [J].
Dong, Jianying ;
Sereno, Arlene ;
Snyder, William B. ;
Miller, Brian R. ;
Tamraz, Susan ;
Doern, Adam ;
Favis, Michael ;
Wu, Xiufeng ;
Tran, Hon ;
Langley, Emma ;
Joseph, Ingrid ;
Boccia, Antonio ;
Kelly, Rebecca ;
Wortham, Kathleen ;
Wang, Qin ;
Berquist, Lisa ;
Huang, Flora ;
Gao, Sharon X. ;
Zhang, Ying ;
Lugovskoy, Alexey ;
Martin, Shelly ;
Gouvis, Heather ;
Berkowitz, Steven ;
Chiang, Gisela ;
Reff, Mitchell ;
Glaser, Scott M. ;
Hariharan, Kandasamy ;
Demarest, Stephen J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (06) :4703-4717
[10]   An introduction to data reduction: space-group determination, scaling and intensity statistics [J].
Evans, Philip R. .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2011, 67 :282-292